USFDA grants Breakthrough Designation to Datar Cancer Genetics for its prostate cancer detection blood test Read more
USFDA authorises first tests that estimate patient’s antibodies from past SARS-CoV-2 infection Read more
COVID-19: Import licenses for rapid diagnostic kits of three firms cancelled, 16 suspended by DCGI Read more
Phase 3 COVID 19 clinical trials to be designed with stringent success criteria: International Regulators Read more